[b]CERP >> MASSIVE NASDAQ NEWZZ/ NASDAQ Grants Cereplast, Inc. [/b]180-Day Extension to Regain Compliance With Minimum Bid Price Rule
2012-11-05 08:00 ET - News Release
EL SEGUNDO, Calif., Nov. 5, 2012 (GLOBE NEWSWIRE) -- Cereplast, Inc. (Nasdaq:CERP), a leading manufacturer of proprietary biobased, sustainable bioplastics, today announced that The NASDAQ Stock Market ("NASDAQ") has granted CERP an additional 180 days to regain compliance with NASDAQ's $1.00 minimum bid price rule under NASDAQ Marketplace Rule 5810(c)(3)(A). Previously, on May 1, 2012, CERP was notified by NASDAQ that CERP did not meet the minimum bid price rule required for continued listing and was given until November 1, 2012 to achieve compliance.
CERP may achieve compliance during the 180-day period if the closing bid price of CERP's common stock is at least a $1.00 per share for a minimum of 10 consecutive business days before April 29, 2013.
About Cereplast, Inc.
Cereplast, Inc. (Nasdaq:CERP) designs and manufactures proprietary biobased, sustainable bioplastics which are used as substitutes for traditional plastics in all major converting processes - such as injection molding, thermoforming, blow molding and extrusions - at a pricing structure that is competitive with traditional plastics. On the cutting-edge of biobased plastic material development, Cereplast now offers resins to meet a variety of customer demands. Cereplast Compostables® resins are ideally suited for single-use applications where high biobased content and compostability are advantageous, especially in the food service industry. Cereplast Sustainables® resins combine high biobased content with the durability and endurance of traditional plastic, making them ideal for applications in industries such as automotive, consumer electronics and packaging. Learn more at www.cereplast.com. You may also visit the Cereplast social networking pages at Facebook.com/Cereplast, Twitter.com/Cereplast and Youtube.com/Cereplastinc.
The Cereplast, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=9567
CONTACT: Cereplast, Inc.
Public Relations
Nicole Robertson
(310) 615-1900 x154
nrobertson@cereplast.com
Investor Relations:
Alliance Advisors, LLC
Alan Sheinwald
914-669-0222
asheinwald@allianceadvisors.net
www.AllianceAdvisors.net
CERP MASSIVE NASDAQ NEWZZ/ NASDAQ Grants Cereplast, Inc.
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Explore Rosanne Cash's Journey in a Unique Exhibition
Rosanne Cash Exhibition at the Country Music Hall of Fame The Country Music Hall of Fame and Museum is set to showcase a remarkable exhibition centered on the influential career of Rosanne Cash. This exhibition, titled "Rosanne Cash: Time Is a Mirror," will delve into her extensive journey as an artist, encompassing her evolution as a songwriter and storyteller....
Continue Reading
Transforming Moving Services in Boston: A Commitment to Excellence
Transforming Moving Services for Boston Residents Boston's vibrant atmosphere has led to an increased demand for efficient and modern moving solutions. Safe Responsible Movers is dedicated to meeting these needs, offering top-notch services tailored to the specific challenges that both residents and businesses experience. With a solid reputation established over the...
Continue Reading
Endeavour Mining Completes Share Buyback with Significant Volume
Endeavour Mining's Recent Share Buyback Announcement Endeavour Mining plc has made a notable step in its commitment to returning value to shareholders through the recent purchase of its ordinary shares. The company has acquired shares from Stifel Nicolaus Europe Limited, marking a significant move in its ongoing buyback program. Aggregated Information on the Share...
Continue Reading
Kristi Vassak Steps Up as COO of Lenox Advisors to Lead Growth
Kristi Vassak Takes on Key Role at Lenox Advisors Lenox Advisors, an esteemed wealth management and insurance advisory firm, has appointed Kristi Vassak as Chief Operating Officer. This significant promotion reflects not only her extensive tenure but also her transformative leadership within the company. As a long-term employee who joined the firm in 2005, Vassak has...
Continue Reading
Werewolf Therapeutics Showcases Innovations at Kidney Cancer Summit
Werewolf Therapeutics Engages at Kidney Cancer Research Summit WATERTOWN, Mass. — Werewolf Therapeutics, Inc. (the "Company" or "Werewolf") (Nasdaq: HOWL), a forward-thinking biopharmaceutical company, is making strides in its mission to revolutionize cancer treatment through conditionally activated therapeutics. This approach aims to empower the body’s immune system...
Continue Reading